Monday 8th December 2014
To download the final programme, please click on the icon on the right hand side.
Welcome address
Dr Sanjay Bhagani, Royal Free Hospital, London, UK
Professor Karine Lacombe, Hôpital Saint-Antoine, Paris, France
The history and basics of HCV virology
Professor Carlo-Federico Perno, University of Rome 'Tor Vergata', Italy
Clinical evaluation of HCV-induced liver disease
Professor Karine Lacombe, Hôpital Saint-Antoine, Paris, France
The impact of HIV on hepatitis C and vice versa
Dr Sanjay Bhagani, Royal Free Hospital, London, UK
Treatment of hepatitis C: who, when and how
Dr Patrick Ingiliz, Medical Center for Infectious Diseases, Berlin (MIB), Germany
End-stage liver disease and its complications
Professor Graham Foster, Queen Mary University of London, UK
Bristol-Myers Squibb supported this Pre-conference Clinical Course by purchasing exhibition stand space and delegate places and has had no input into the selection of speakers or topics
Welcome address
Ms Michelle Croston, National HIV Nurses Association (NHIVNA)
Ms Fiona Fry, Chair, British Association for the Study of the Liver Nurse Forum (BASLNF)
Understanding the hepatitis C virus: a nurse perspective
Mr Dean Linzey, Royal Berkshire NHS Foundation Trust, Reading, UK
A guide to the anatomy and physiology of the liver
Ms Amanda Clements, Plymouth Hospital NHS Foundation Trust, UK
Introduction to blood results, interpretation and nursing priorities
Mrs Janet Catt, Royal Free London NHS Foundation Trust, UK
How will new treatments affect nursing practice?
Mr Ricky Gellissen, Imperial College Healthcare NHS Trust, London, UK
What is the impact of HIV/HCV co-infection in the era of chem sex?
Mr Joe Phillips, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK
The Pre-conference Nurses' Course is organised by the National HIV Nurses Association (NHIVNA) and the British Association for the Study of the Liver Nurses’ Forum (BASLNF)
Introduction and Welcome
Dr Ranjababu Kulasegaram
Chair, Five Nations Conference Steering Committee
Plenary Session 1
The global challenge of HCV
Dr Isabelle Andrieux-Meyer, Médecins Sans Frontières, Geneva, Switzerland
The epidemiology of HIV and viral hepatitis in Europe
Professor Amanda Mocroft, Institute of Epidemiology and Health, London, UK
Clinical case presentations
Once, twice, three times a virus...
Dr Binta Sultan, Mortimer Market Centre, London, UK
Renal impairment during triple therapy with telaprevir for chronic hepatitis C: a case report
Dr Elisa Biliotti, Sapienza University of Rome, Italy
Hepatitis delta is leading infection in HBV/HCV/HDV and HIV patient
Dr Ivana Carey, King’s College Hospital, London, UK
Invited Lecture 1
Liver transplantation in the HIV-infected population
Professor Massimo Puoti, University of Brescia, Italy
Plenary Session 2
Extrahepatic manifestations of HCV: from immune- to inflammation-related manifestations
Professor Patrice Cacoub, La Pitié-Salpêtrière Hospital, Paris, France
Non-alcoholic steatohepatitis (NASH)
Dr Maud Lemoine, Imperial College Healthcare NHS Trust, London, UK
Invited Lecture 2
Hepatocellular carcinoma
Dr Nicolás Merchante, Hospital Universitario de Valme, Sevilla, Spain